Cargando…
Optimization algorithms for functional deimmunization of therapeutic proteins
BACKGROUND: To develop protein therapeutics from exogenous sources, it is necessary to mitigate the risks of eliciting an anti-biotherapeutic immune response. A key aspect of the response is the recognition and surface display by antigen-presenting cells of epitopes, short peptide fragments derived...
Autores principales: | Parker, Andrew S, Zheng, Wei, Griswold, Karl E, Bailey-Kellogg, Chris |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873530/ https://www.ncbi.nlm.nih.gov/pubmed/20380721 http://dx.doi.org/10.1186/1471-2105-11-180 |
Ejemplares similares
-
Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate
por: Salvat, Regina S., et al.
Publicado: (2015) -
Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing
por: Zhao, Hongliang, et al.
Publicado: (2020) -
A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications
por: Mett, Vadim, et al.
Publicado: (2021) -
Deimmunization of protein therapeutics – Recent advances in experimental and computational epitope prediction and deletion
por: Zinsli, Léa V., et al.
Publicado: (2020) -
Design and Engineering of Deimmunized Vaccinia Viral Vectors
por: Song, Kevin, et al.
Publicado: (2020)